ArticleFrontiers in pharmacology2021

Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model.

Xin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.